Clinical Trial: Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional




Official Title: Safety and Efficacy of Low-dose Terlipressin Delivered by Continuous Intravenous Infusion in Patients With Cirrhosis and Ascites Refractory to, or Intolerant of, Diuretic

Brief Summary: Low-dose continuous infusion of terlipressin will be administered to six cirrhotic patients with refractory ascites.